Dr Marco Massarotti

Dr Marco Massarotti is an accomplished Consultant Rheumatologist dedicated to providing comprehensive, compassionate, and patient-focused care for individuals affected by musculoskeletal and rheumatic disorders. He takes a meticulous approach to clinical evaluation, utilising advanced diagnostic techniques to establish accurate diagnoses and construct personalised treatment plans. Dr Massarotti prioritises clear communication and shared decision-making, helping patients effectively manage chronic symptoms, preserve joint function, and maintain their overall quality of life.

In his clinical practice, Dr Massarotti manages a broad spectrum of rheumatological conditions, with special clinical interests in chronic inflammatory arthritis, such as rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis. He also possesses extensive expertise in evaluating and treating crystal arthritis, including gout and calcium pyrophosphate deposition disease (CPPD or pseudogout), alongside osteoporosis and metabolic bone diseases. Furthermore, he is highly skilled in musculoskeletal ultrasound, using point-of-care imaging to enhance diagnostic precision and monitor disease activity in inflammatory joint conditions, connective tissue diseases, vasculitis, and polymyalgia rheumatica.

Dr Massarotti completed his medical degree and specialist postgraduate training in rheumatology in Milan, Italy, and achieved UK registration in 2016. In 2018, he was awarded a competency diploma in musculoskeletal ultrasound in rheumatology by the European Federation of Societies for Ultrasound in Medicine and Biology. An active contributor to clinical research, he has participated in clinical trials and authored numerous scientific articles in peer-reviewed medical journals. He holds professional memberships with the Royal College of Physicians of London, the British Medical Association, the British Society for Rheumatology, the British Psoriatic Arthritis Consortium, the British Society for Spondyloarthritis, the Royal Osteoporosis Society, the Group for Research and Assessment of Psoriasis and Psoriatic Arthritis, the American Society for Bone and Mineral Research, and the European Calcified Tissue Society.